Research Focus

Former Employee. Pharmacy; Clinical Pharmacy Specialist I

Recent additions – View all

1. Rapid infusion rituximab is well tolerated in patients with primary CNS lymphoma

   Journal Article

   Modelevsky, L.; Tizon, R.; Reiss, S. N.; Smith, M.; Garonce, R.; Kaley, T.
   CNS Oncology (2018)

   Fulltext@MSK | Save
2. Safety and feasibility of rapid rituximab infusions in patients with primary CNS lymphoma

   Meeting Abstract

   Modelevsky, L.; Tizon, R.; Garonce, R.; Reiss, S.; Kaley, T.
   Neuro-Oncology (2016)

   Fulltext@MSK | Save